CANDRIAM S.C.A. – Neurocrine Biosciences, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$28.83M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -17.96% | -59.44K shares | -3.42M | $106.21 | 271.48K |
| Q2 2022 | share | Increase | +10.23% | 30.72K shares | 4.11M | $97.48 | 330.92K |
| Q1 2022 | share | Decrease | -3.13% | -9.70K shares | 1.74M | $93.75 | 300.20K |
| Q4 2021 | share | Increase | +280.20% | 228.4K shares | 18.57M | $84.63 | 309.91K |
| Q3 2021 | share | Increase | +0.02% | 20 shares | -113K | $95.91 | 81.51K |
| Q2 2021 | share | Decrease | -49.84% | -80.97K shares | -8.01M | $97.32 | 81.49K |
| Q1 2021 | share | 0.00% | 0 shares | -656K | $97.25 | 162.46K | |
| Q4 2020 | share | Increase | +3.96% | 6.18K shares | 1.57M | $95.85 | 162.46K |
| Q3 2020 | share | 0.00% | 0 shares | -4.04M | $96.16 | 156.28K | |
| Q2 2020 | share | Decrease | -16.32% | -30.48K shares | -558K | $122 | 156.28K |
| Q1 2020 | share | 0.00% | 0 shares | -450K | $86.55 | 186.76K | |
| Q4 2019 | share | Decrease | -8.75% | -17.90K shares | 1.63M | $107.49 | 186.76K |
| Q3 2019 | share | Decrease | -23.54% | -63K shares | -4.05M | $90.11 | 204.66K |
| Q2 2019 | share | Decrease | -8.54% | -25K shares | -3.28M | $84.43 | 267.66K |
| Q1 2019 | share | Increase | +28.32% | 64.6K shares | 9.49M | $88.1 | 292.66K |
| Q4 2018 | share | Increase | +51.98% | 78K shares | -2.16M | $71.41 | 228.06K |
| Q3 2018 | share | Increase | +87.35% | 69.96K shares | 10.58M | $122.95 | 150.06K |
| Q2 2018 | share | Increase | +23.23% | 15.1K shares | 2.47M | $98.24 | 80.1K |
| Q1 2018 | share | Decrease | -35.00% | -35K shares | -2.36M | $82.93 | 65K |
| Q4 2017 | share | Decrease | -74.49% | -292K shares | -16.26M | $77.59 | 100K |
| Q3 2017 | share | Decrease | -14.97% | -69K shares | 2.81M | $61.28 | 392K |
| Q2 2017 | share | Increase | +86.64% | 214K shares | 10.51M | $46 | 461K |
| Q1 2017 | share | Increase | +46.15% | 78K shares | 4.15M | $43.3 | 247K |
| Q4 2016 | share | Increase | +37.40% | 46K shares | 311K | $38.7 | 169K |
| Q3 2016 | share | Increase | +5.76% | 6.7K shares | 943K | $50.64 | 123K |
| Q2 2016 | share | Decrease | -2.27% | -2.7K shares | 605K | $45.45 | 116.3K |
| Q1 2016 | share | Increase | +6.25% | 7K shares | -1.65M | $39.55 | 119K |